Gérard Soula
Founder en ADOCIA .
Fortuna: 10 M $ al 31/03/2024
Origen de la red de primer grado Gérard Soula.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
20
| Public Company | Pharmaceuticals: Major | 20 |
Flamel Technologies SA
 Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France.
13
| Extinct | Pharmaceuticals: Major | 13 |
GLOWBL SAS
 GLOWBL SAS Packaged SoftwareTechnology Services GLOWBL SAS designs and develops communications software for videoconferencing and content sharing. It enables users to share media content and live events. The company was founded in 2011 and is headquartered in Lyon, France.
3
| Private Company | Packaged Software | 3 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Gérard Soula a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| BECTON, DICKINSON AND COMPANY | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Alta Partners Management Co. LP
 Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Investment Managers | Founder Private Equity Investor | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Sales & Marketing | |
| TRANSGENE | Biotechnology | Director of Finance/CFO Director/Board Member | |
| SANOFI | Pharmaceuticals: Major | Director of Finance/CFO | |
| Aventis, Inc. | Comptroller/Controller/Auditor | ||
Universal Cells, Inc.
 Universal Cells, Inc. BiotechnologyHealth Technology Universal Cells, Inc. develops, licenses and commercializes stem cell therapies. The company was founded by Claudia Mitchell and David Russell and is headquartered in Seattle, WA. | Biotechnology | Chief Executive Officer | |
| University of Bradford | College/University | Undergraduate Degree | |
| ASTELLAS PHARMA INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO | |
| THERADIAG | Medical Specialties | Chief Executive Officer Director/Board Member | |
| NEOVACS | Pharmaceuticals: Major | Director/Board Member | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Corporation de l'École Polytechnique de Montréal | College/University | Undergraduate Degree | |
| EM Lyon Business School | College/University | Undergraduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Masters Business Admin | |
| Ecole Nationale Supérieure de Chimie de Montpellier | College/University | Doctorate Degree | |
PricewaterhouseCoopers Audit SA
 PricewaterhouseCoopers Audit SA Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers Audit SA provides accounting, auditing and consulting services. The company was founded on February 10, 1967 and is headquartered in Neuilly-sur-Seine, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Washington Biotechnology & Biomedical Association | Director/Board Member | ||
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Truffle Capital SAS
 Truffle Capital SAS Investment ManagersFinance Truffle Capital SAS is an Independent Venture Capital firm founded in 2000. Truffle Capital is headquartered in Paris. | Investment Managers | Private Equity Analyst | |
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Biotechnology | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| University of Lyon | College/University | Undergraduate Degree | |
| TXCELL | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
CDC Croissance SA
 CDC Croissance SA Investment ManagersFinance CDC Croissance SA is an asset management firm headquartered in Paris, France. It was founded in 2001 as CDC Entreprises Valeurs Moyennes SAS. The firm is a subsidiary of BPIFrance Investissement, which in turn is a subsidiary of government-owned Caisse d'Amortissement de la Dette Sociale. CDC Croissance manages assets of individual and institutional clients. | Investment Managers | Chief Investment Officer Corporate Officer/Principal | |
| CARMAT | Medical Specialties | Director/Board Member | |
Kurma Partners SA
 Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor Director/Board Member | |
| Holding Incubatrice Biotechnologie | Investment Managers | Chief Executive Officer | |
| École Supérieure de Chimie Physique Électronique | College/University | Undergraduate Degree Doctorate Degree | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
Prestizia SASU
 Prestizia SASU Miscellaneous Commercial ServicesCommercial Services Part of Biosynex SA, Prestizia SASU is a French company that provides biotechnology research and development services. The private company is based in Paris, France. Odile Prigneau has been the CEO of the company since 2013. Prestizia was acquired by Theradiag SA, a subsidiary of Biosynex SA from Truffle Capital SAS on June 27, 2012. | Miscellaneous Commercial Services | Chairman | |
Platine Pharma Services SAS
 Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Based in Lyon within the Center of excellence in Infectious Diseases, Platine Pharma Services is an essential source of immune information for scientists and clinicians. From protocol support to regulatory reports, the company designs, performs and interprets complex molecular and cellular assays. Platine actively supports the development of in-vitro diagnostic, cosmetic and therapeutic product candidates, highlighting key markers and features in both normal and pathological conditions, and guiding decisions at each development stage. Using state-of-the-art technologies such as multi-parametric flow cytometry, Singulex, Luminex, Mesoscale Discovery, ELISpot or ELISA, Platine Pharma Services offers a fit-for-purpose approach to its customers and partners. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| ELSALYS BIOTECH | Pharmaceuticals: Major | Chairman Director/Board Member | |
iSTAR Medical SA
 iSTAR Medical SA Medical SpecialtiesHealth Technology iSTAR Medical SA develops innovative ophthalmic implants. Its products include MINIject, STARflo and STAR Material. The company was founded by Michel Alvarez in 2011 and is headquartered in Wavre, Belgium. | Medical Specialties | Director/Board Member Chief Executive Officer | |
Cellphire, Inc.
 Cellphire, Inc. BiotechnologyHealth Technology Cellphire, Inc. develops proprietary method for the long-term stabilization of platelets in the dry state. It focuses on developing stabilized cellular materials for advanced technologies in the therapeutic and diagnostic markets through its proprietary cell stabilization technology. The company was founded by Richard O. Cliff in 2005 and is headquartered in Rockville, MD. | Biotechnology | Chairman Chief Executive Officer Director/Board Member | |
| MAAT PHARMA | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
| AVADEL PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director of Finance/CFO | |
Horama SA
 Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
SparingVision SAS
 SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | Biotechnology | Director/Board Member Chief Executive Officer | |
| AFFLUENT MEDICAL | Medical Specialties | Chief Executive Officer | |
| Ecole Des Ponts Business School | College/University | Masters Business Admin | |
Argobio SAS
 Argobio SAS Miscellaneous Commercial ServicesCommercial Services Argobio SAS is a start-up studio founded in 2021 and based in Paris, FR. The company was initiated by Kurma Partners, a leading healthcare venture capital firm based in France, and Bpifrance, the French national investment bank. The French company aims to nurture and launch at least five breakthrough biotech companies over the next five years by sourcing innovative early-stage projects from renowned European academic research institutions. The focus is on selected therapeutic areas, including rare diseases, neurological disorders, oncology, and immunology. Argobio will identify, select, and incubate these projects up to company creation and beyond, providing broad expertise in the discovery and development of novel drugs with a team of highly experienced biotech entrepreneurs. The internal team is led by Yves Ribeill, Neill Mackenzie, Poul Sørensen, and Rémi Soula. Thierry Laugel, Managing Partner at Partners, is the President of Argobio. Kurma and Bpifrance were joined by complementary strategic investors, Angelini Pharma, a private international pharmaceutical company, Evotec, a drug discovery alliance and development partnership company, and the Institut Pasteur, an internationally renowned center for biomedical research. | Miscellaneous Commercial Services | President Chairman |
Estadísticas
Internacional
| Francia | 35 |
| Estados Unidos | 10 |
| Reino Unido | 2 |
| Japón | 2 |
| Canadá | 2 |
Sectorial
| Health Technology | 28 |
| Consumer Services | 9 |
| Finance | 7 |
| Commercial Services | 5 |
| Health Services | 3 |
Operativa
| Director/Board Member | 169 |
| Corporate Officer/Principal | 50 |
| Chairman | 25 |
| Independent Dir/Board Member | 22 |
| Chief Executive Officer | 20 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Elie Vannier | 29 |
| Stéphane Boissel | 24 |
| Jean Deleage | 23 |
| Dominique Takizawa | 23 |
| Ekaterina Smirnyagina | 21 |
| Laurent Arthaud | 21 |
| Olivier Martinez | 19 |
| Thierry Laugel | 18 |
| John Ludwig Vogelstein | 16 |
| Katherine Bowdish | 15 |
| Michel Finance | 15 |
| Bruce S. Morra | 14 |
| Claudia Mitchell | 12 |
| Jérôme Féraud | 12 |
| Stephen Willard | 11 |
- Bolsa de valores
- Insiders
- Gérard Soula
- Conexiones Empresas
